☆ 4.8 Editorial Material

Acalabrutinib in mantle cell lymphoma

LANCET (2018)

Get Full Text
Add to Collection

Journal

LANCET
Volume 391, Issue 10121, Pages 633-634

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)33256-7

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. Takeda
  2. Sanofi
  3. Amgen
  4. Bristol-Squibbs Myers
  5. Affimed
  6. Seattle Genetics
  7. Regeneron
  8. Trillium

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.